SETD2 and neoplasm: However, Liu et al. reported that the combined score according to SETD2/H3K36me3 expression was an independent prognostic factor for OS and DFS, which was associated with tumor size (p = 0.003), pT stage (p = 0.043), and sarcomatoid component (p = 0.004) [30].